Back to top

Cellebrite DI (CLBT) Receives a Rating Update from a Top Analyst

In a report released today, Shaul Eyal from TD Cowen reiterated a Buy rating on Cellebrite DI, with a price target of $25.00. The company’s shares ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Cellebrite DI Ltd. (CLBT)